Clinical Trial Update: rhTPO Combining Dexamethasone Versus High-dose Dexamethasone for Initial Treatment of ITP [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing rhTPO plus dexamethasone versus high-dose dexamethasone for initial treatment of immune thrombocytopenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• rhTPO (recombinant human thrombopoietin)

Snippet

Sponsor: Shandong University | Conditions: Purpura, Idiopathic Thrombocytopenic Purpura | Phase 3 | Status: COMPLETED